AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 4 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- 10+ awardsAwards on record
Key stats
Fundamentals Sep 30- Open
- $40.58
- 52-wk high
- $49.91
- High
- $40.80
- 52-wk low
- $40.40
- Low
- $40.40
- Prev close
- $41.18
- Mkt cap
- $97.62B
- P/E
- 22.4x
- Volume
- 3.04M
- Fwd P/E
- 8.6x
- Beta
- 0.28
- Div yield
- 10.00%
- P/S
- 2.0x
- P/B
- 1.3x
- Profit margin
- +8.1%
- Op margin
- +21.0%
- ROE
- +5.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about SNY filings
Are insiders buying or selling Sanofi ADR (SNY) stock?
Neither. Sanofi ADR (SNY) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded SNY recently?
None. No member of Congress disclosed a SNY trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this SNY smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
How top traders are positioned
No tracked top-trader positions in SNY right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 10.0% above what analysts expected.
Earnings per share
$1.10 expected
Reports Oct 23, 2026, in 22 days
Estimates as of Sep 30, 2026
EPS expected
$1.54 to $1.58
Revenue expected
6 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
Is the business strong?
Reasonably priced and running thin margins.
- Net margin
- 8.1%
- P/E
- 22.38
- Forward P/E
- 8.59
- Market cap
- $97.6B
Valuation
- P/S2.00
- P/B1.28
- Dividend yield10.0%
Quality
- Operating margin21.0%
- ROE5.7%
- ROA5.1%
Growth
- Beta0.28
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace